Duchenne muscular dystrophy (DMD) is a fatal genetic disorder caused by mutations in the DMD gene. Here, the authors develop MyoAAV-UA, a compact utrophin activator, as a promising universal treatment for DMD through a homologous protein activation approach.
- Ruo Wu
- Peng Li
- Yongchang Chen
